resolvin-d2 and Periodontitis

resolvin-d2 has been researched along with Periodontitis* in 2 studies

Other Studies

2 other study(ies) available for resolvin-d2 and Periodontitis

ArticleYear
Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis.
    Frontiers in immunology, 2018, Volume: 9

    Periodontitis is an infectious inflammatory disease of the supporting structures of the teeth. Resolvins are part of a large family of specialized pro-resolving lipid mediators that enhance active resolution of inflammation and return of inflammatory lesions to homeostasis. In this paper, we demonstrate that resolvin D2 (RvD2), a product of docosahexaenoic acid (DHA) metabolism, prevents alveolar bone loss in

    Topics: Alveolar Bone Loss; Animals; Docosahexaenoic Acids; Female; Immunity, Innate; Mice; Mice, Inbred BALB C; Periodontitis; Th1 Cells

2018
Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway.
    Nature communications, 2015, Sep-16, Volume: 6

    Del-1 is an endothelial cell-secreted anti-inflammatory protein. In humans and mice, Del-1 expression is inversely related to that of IL-17, which inhibits Del-1 through hitherto unidentified mechanism(s). Here we show that IL-17 downregulates human endothelial cell expression of Del-1 by targeting a critical transcription factor, C/EBPβ. Specifically, IL-17 causes GSK-3β-dependent phosphorylation of C/EBPβ, which is associated with diminished C/EBPβ binding to the Del-1 promoter and suppressed Del-1 expression. This inhibitory action of IL-17 can be reversed at the GSK-3β level by PI3K/Akt signalling induced by D-resolvins. The biological relevance of this regulatory network is confirmed in a mouse model of inflammatory periodontitis. Intriguingly, resolvin-D1 (RvD1) confers protection against IL-17-driven periodontal bone loss in a Del-1-dependent manner, indicating an RvD1-Del-1 axis against IL-17-induced pathological inflammation. The dissection of signalling pathways regulating Del-1 expression provides potential targets to treat inflammatory diseases associated with diminished Del-1 expression, such as periodontitis and multiple sclerosis.

    Topics: Alveolar Bone Loss; Animals; Calcium-Binding Proteins; Carrier Proteins; CCAAT-Enhancer-Binding Protein-beta; Cell Adhesion Molecules; Chromatin Immunoprecipitation; Disease Models, Animal; Docosahexaenoic Acids; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Gingiva; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Human Umbilical Vein Endothelial Cells; Humans; Immunoblotting; Immunoprecipitation; Intercellular Signaling Peptides and Proteins; Interleukin-17; Mice; Mice, Knockout; Periodontitis; Peroxidase; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Signal Transduction

2015